Colorectal Cancer
FDA Approves Entrogen's RAS Mutation Detection Kit as CDx for Vectibix
The test, intended for use with Amgen's Vectibix, detects KRAS and NRAS exon 2, 3, and 4 mutations in colorectal cancer patients.
Mainz Biomed Stock Spikes on Positive Data for mRNA-Enhanced Colorectal Cancer Screening Assay
In top-line data, Mainz Biomed's enhanced ColoAlert detected CRC with 94 percent sensitivity and 97 percent specificity, and advanced adenoma with 81 percent sensitivity.
Researchers conducted a trial that tested the activity of anti-SHP2 monotherapy and personalized combination regimens across different genetically altered tumor types.
Atrium Health Rolls Out In-House DPYD Testing, EHR Prompts to Spur PGx Adoption in Cancer Clinics
Premium
After successfully piloting testing at two clinics, the health system considers DPYD testing standard care for cancer patients prescribed fluoropyrimidines at all its care sites.
DoMore Diagnostics, Proscia Ink Collaboration on Colorectal Cancer Histopathology Testing
The digital pathology firms will combine their technologies to help pathologists predict patient outcomes and incorporate AI-supported decision-making.